MTOR and glomerulosclerosis: mTOR-mediated podocyte hypertrophy during podocyte loss seems to be crucial to maintain glomerular functional integrity, as pharmacological mTOR-inhibition during acute podocyte loss resulted in albuminuria, PEC-activation and glomerulosclerosis in mice (48).